Rhumbline Advisers Third Harmonic Bio, Inc. Transaction History
Rhumbline Advisers
- $109 Billion
- Q3 2024
A detailed history of Rhumbline Advisers transactions in Third Harmonic Bio, Inc. stock. As of the latest transaction made, Rhumbline Advisers holds 28,720 shares of THRD stock, worth $328,844. This represents 0.0% of its overall portfolio holdings.
Number of Shares
28,720
Previous 28,601
0.42%
Holding current value
$328,844
Previous $371,000
4.85%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding THRD
# of Institutions
83Shares Held
43.6MCall Options Held
7.1KPut Options Held
0-
Atlas Venture Life Science Advisors, LLC10.9MShares$125 Million18.24% of portfolio
-
Orbimed Advisors LLC San Diego, CA5.78MShares$66.2 Million1.85% of portfolio
-
Bvf Inc San Francisco, CA4.37MShares$50 Million1.88% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA3.18MShares$36.4 Million1.87% of portfolio
-
General Atlantic LLC New York, NY2.96MShares$33.9 Million1.15% of portfolio
About Third Harmonic Bio, Inc.
- Ticker THRD
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,328,900
- Market Cap $462M